Video Aug 27, 2021
What Types of Claims Can We Expect to See Filed as a Result of COVID-19?
Marco Spadacenta, Senior Vice President of Claims for The Doctors Company, details the different kinds of claims we may see filed as a result of the pandemic.
Search
September 05, 2024, Becker's Physician Leadership
5 Notes on the Rise of Malpractice Verdicts
Robert White, President of The Doctors Company and TDC Group, discusses how a rollback of tort reforms across the country is one contributor of the rise of malpractice verdicts.
Video Sep 11, 2024
Is This Healthcare's AI Moment?
Robert Wachter, MD, Internist; Chair, Department of Medicine, University of California, San Francisco; and Member of the Board of Governors for The Doctors Company, part of TDC Group, asks top experts who gathered at the TDC Group 2024 Executive Advisory Board Meeting, “Is this healthcare’s AI moment?”
Video Sep 11, 2024
A Medical Consult with GPT-4
Robert Wachter, MD, consults ChatGPT regarding a challenging patient case during the TDC Group 2024 Executive Advisory Board Meeting. Dr. Wachter is an Internist; Chair, Department of Medicine, University of California, San Francisco; and Member of the Board of Governors for The Doctors Company, part of TDC Group.
Aug 06, 2021
The Malpractice Experience of Neurosurgeons 2014–2019: Patient Selection and Communication May Mitigate Risk of Claims (Abstract)
The Doctors Company conducted an analysis of medical malpractice claims against neurosurgeons that closed between the years of 2014 and 2019. This evaluation included 302 claims and lawsuits, and examined allegations, diagnoses, procedures, and contributing factors, as well as indemnities and expenses paid. The claims experience of neurosurgeon members of The Doctors Company was then benchmarked against a national sample of other neurosurgeons.
Sep 01, 2023
Industry and Company News
Announcements in the third quarter of 2023: an appointment to our Board of Governors, the passing of a co-founding board member, and the results of our 2022 Member Experience Survey.
From
The Doctor’s Advocate
Professional Education
Delayed Diagnosis of Malignancy: Case Review for Advanced Practice Clinicians
In reviewing closed malpractice claims, The Doctors Company identified delayed diagnosis of a malignancy as a reoccurring problem. The following highlights the importance of recognizing a spinal abnormality and recommending further follow up of a lesion seen on imaging. Contributing factors include misinterpretation of radiologic studies, narrow diagnostic focus, lack of communication, and failure to establish a differential diagnosis.
December 10, 2024, Medscape
Malpractice in the Age of AI
Deepika Srivastava, Chief Operating Officer of The Doctors Company, part of TDC Group, provides insights on the intersection of artificial intelligence (AI) and malpractice risk in healthcare.
The Doctors Company Names Megan Mahoney, MD, MBA, to Board of Governors
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, is pleased to announce the appointment of Megan Mahoney, MD, MBA, to its Board of Governors. Dr. Mahoney is Chief of Staff for Stanford Health Care and Professor of Medicine at Stanford University School of Medicine.